---
figid: PMC7926484__cells-10-00477-g003
figtitle: Dysregulated pathways governing liver hepcidin expression in PAH
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC7926484
filename: cells-10-00477-g003.jpg
figlink: pmc/articles/PMC7926484/figure/cells-10-00477-f003/
number: F3
caption: 'Dysregulated pathways governing liver hepcidin expression in PAH. When intestinal
  iron intake increases, holo-Tf level increases accordingly. High levels of holo-Tf
  are sensed by hepatocytes through HFE/TfR2 signaling, which induces BMP6 expression
  through ERK1/2 activation. Once secreted, BMP6 binds to TGF-β and BMP receptors,
  leading to SMAD signaling and hepcidin (HAMP) genetic expression. The IL6R pathway
  also induces ERK1/2 activation and further BMP6 expression in hepatocytes but can
  also activate HAMP transcription directly through STAT3 activation. In contrast,
  stabilized HIF-2α downregulates HAMP transcription and thus lowers hepatic hepcidin
  expression. Green arrows: expression or signaling enhanced in PAH; red arrows: expression
  or signaling decreased in PAH; green bold arrows: BMP signaling switch in PAH. ActRIIa:
  activin type IIa receptor, Alk2/3: activin receptor-like kinase 2/3, BMP: bone morphogenetic
  protein, BMPR-II: bone morphogenetic protein receptor type II, ERK1/2: extracellular
  signal-regulated kinase 1/2, HAMP: hepcidin-coding gene, HIF-2α: hypoxia-inducible
  factor 2α, holo-Tf: holo-transferrin, IL6R: interleukin-6 receptor, SMAD: small
  mothers against decapentaplegic, STAT3: signal transducer and activator of transcription
  3, TfR2: transferrin receptor 2, pVHL: von Hippel–Lindau protein.'
papertitle: 'Iron Deficiency in Pulmonary Arterial Hypertension: A Deep Dive into
  the Mechanisms.'
reftext: Marceau Quatredeniers, et al. Cells. 2021 Feb;10(2):477.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9645026
figid_alias: PMC7926484__F3
figtype: Figure
redirect_from: /figures/PMC7926484__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7926484__cells-10-00477-g003.html
  '@type': Dataset
  description: 'Dysregulated pathways governing liver hepcidin expression in PAH.
    When intestinal iron intake increases, holo-Tf level increases accordingly. High
    levels of holo-Tf are sensed by hepatocytes through HFE/TfR2 signaling, which
    induces BMP6 expression through ERK1/2 activation. Once secreted, BMP6 binds to
    TGF-β and BMP receptors, leading to SMAD signaling and hepcidin (HAMP) genetic
    expression. The IL6R pathway also induces ERK1/2 activation and further BMP6 expression
    in hepatocytes but can also activate HAMP transcription directly through STAT3
    activation. In contrast, stabilized HIF-2α downregulates HAMP transcription and
    thus lowers hepatic hepcidin expression. Green arrows: expression or signaling
    enhanced in PAH; red arrows: expression or signaling decreased in PAH; green bold
    arrows: BMP signaling switch in PAH. ActRIIa: activin type IIa receptor, Alk2/3:
    activin receptor-like kinase 2/3, BMP: bone morphogenetic protein, BMPR-II: bone
    morphogenetic protein receptor type II, ERK1/2: extracellular signal-regulated
    kinase 1/2, HAMP: hepcidin-coding gene, HIF-2α: hypoxia-inducible factor 2α, holo-Tf:
    holo-transferrin, IL6R: interleukin-6 receptor, SMAD: small mothers against decapentaplegic,
    STAT3: signal transducer and activator of transcription 3, TfR2: transferrin receptor
    2, pVHL: von Hippel–Lindau protein.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BMP6
  - BMP7
  - IL6
  - ACVRL1
  - ALK
  - SLPI
  - BMPR1A
  - ACVR1
  - GPR162
  - AURKB
  - AURKC
  - BMPR2
  - TFR2
  - SMAD2
  - SMAD3
  - SMAD4
  - SMAD5
  - SMAD9
  - SMAD1
  - GARS1
  - MAPK3
  - MAPK1
  - STAT3
  - VHL
  - EPAS1
  - HAMP
  - HFE
  - FGFR3
  - ACH
---
